Shivalik Rasayan Limited updates on DMF

Shivalik Rasayan Limited has announced that Centre for Drug Evaluation (CDE), China has acknowledged the Drug Master File (DMF) of Bendamustine API. Now the process of evaluations and approval is underway.

Shares of Shivalik Rasayan Ltd was last trading in BSE at Rs. 753.60 as compared to the previous close of Rs. 771.70. The total number of shares traded during the day was 3735 in over 369 trades.

The stock hit an intraday high of Rs. 790.00 and intraday low of 745.00. The net turnover during the day was Rs. 2878076.00.

Source : Equity Bulls

Keywords

ShivalikRasayan INE788J01021 CDE China DMF BendamustineAPI